Fennec Pharmaceuticals
Price & Volume
Stats
See moreOpen | $6.26 |
Previous Close | $6.25 |
Day Range | $6.26-$6.36 |
52W Range | $5.02-$9.92 |
Market Cap | $204.4M |
Shares Short | 913,271 |
Financials
See moreRevenue (12 Mos) | $44.6M |
Revenue Growth (YoY) | 73.8% |
Gross Profit (12 Mos) | $40.8M |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 8 days ago
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Yahoo Finance • 15 days ago
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 22 days ago
Adherex Technologies Q4 Earnings Call Highlights
Yahoo Finance • 28 days ago
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
About
CEO | Mr. Jeffrey S. Hackman |
Address | 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |
